Anthony David
Overview
Explore the profile of Anthony David including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-San-Martin N, Bethlehem R, Mihalik A, Seidlitz J, Sebenius I, Aleman-Morillo C, et al.
Mol Psychiatry
. 2024 Sep;
PMID: 39266711
The psychosis spectrum encompasses a heterogeneous range of clinical conditions associated with abnormal brain development. Detecting patterns of atypical neuroanatomical maturation across psychiatric disorders requires an interpretable metric standardized by...
2.
Ho B, Barry A, Koeppel J, Macleod J, Boyd A, David A, et al.
Biol Psychiatry Glob Open Sci
. 2023 May;
3(2):222-232.
PMID: 37124347
Background: We investigated how low marijuana (MJ) use levels, the typical use pattern in most adolescent users, affect cognitive maturation and schizophrenia risk. Methods: In two complementary adolescent samples where...
3.
Merritt K, McCutcheon R, Aleman A, Ashley S, Beck K, Block W, et al.
Mol Psychiatry
. 2023 Feb;
28(5):2039-2048.
PMID: 36806762
Glutamatergic dysfunction is implicated in schizophrenia pathoaetiology, but this may vary in extent between patients. It is unclear whether inter-individual variability in glutamate is greater in schizophrenia than the general...
4.
Revill G, Carlisi C, David A, Poole N, Bell V
Lancet Neurol
. 2023 Jan;
22(2):109-110.
PMID: 36681440
No abstract available.
5.
Saini A, Begum N, Matti J, Ghanem D, Fripp L, Pollak T, et al.
Schizophr Res
. 2022 Sep;
263:275-281.
PMID: 36117082
Catatonia is a neuropsychiatric disorder characterised by altered movement, speech, and behaviour. Clozapine is an established therapy for treatment-resistant schizophrenia, but its role in catatonia has not been systematically examined....
6.
Blackman G, Lim M, Pollak T, Al-Diwani A, Symmonds M, Mazumder A, et al.
J Neurol
. 2022 Jul;
269(10):5302-5311.
PMID: 35790561
Background: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR...
7.
Pollak T, Vincent A, Iyegbe C, Coutinho E, Jacobson L, Rujescu D, et al.
Biol Psychiatry
. 2021 Feb;
90(1):9-15.
PMID: 33536130
Background: When psychosis develops in NMDA receptor (NMDAR) antibody encephalitis, it usually has an acute or subacute onset, and antipsychotic treatment may be ineffective and associated with adverse effects. Serum...
8.
Ajnakina O, Agbedjro D, Lally J, Di Forti M, Trotta A, Mondelli V, et al.
Psychiatry Res
. 2020 Oct;
294:113527.
PMID: 33126015
Evidence suggests there are two treatment-resistant schizophrenia subtypes (i.e. early treatment resistant (E-TR) and late-treatment resistant (L-TR)). We aimed to develop prediction models for estimating individual risk for these outcomes...
9.
Chalder T, Patel M, James K, Hotopf M, Frank P, Watts K, et al.
BMC Psychiatry
. 2020 Aug;
20(1):403.
PMID: 32787819
An amendment to this paper has been published and can be accessed via the original article.
10.
Jardet C, David A, Braun E, Descargues P, Grolleau J, Hebsgaard J, et al.
Exp Dermatol
. 2020 Aug;
29(10):993-1003.
PMID: 32737987
Skin models mimicking features of psoriasis-related inflammation are needed to support the development of new drugs in dermatology. Reconstructed skin models lack tissue complexity, including a fully competent skin barrier,...